Correction of mucopolysaccharidosis type IIIB fibroblasts by lentiviral vector-mediated gene transfer

Guglielmo R D Villani, Antonia Follenzi, Borghina Vanacore, Carmela Di Domenico, Luigi Naldini, Paola Di Natale

Research output: Contribution to journalArticle

Abstract

Mucopolysaccharidosis type IIIB (MPS IIIB; or Sanfilippo syndrome type B) is a lysosomal disease, due to glycosaminoglycan storage caused by mutations on the α-N-acetylglucosaminidase (NAGLU) gene. The disease is characterized by neurological dysfunction but relatively mild somatic manifestations. No effective treatment is available for affected patients. In the present study, we evaluated the role of a lentiviral vector as the transducing agent of NAGLU cDNA in MPS IIIB fibroblasts. The vector expressed high transduction efficiency and high levels of enzymic activity, 20-fold above normal levels, persisting for at least 2 months. PCR experiments confirmed the integration of the viral vector into the target genome. The NAGLU activity restored by virus infection was sufficient to normalize glycosaminoglycan accumulation, which is directly responsible for the disease phenotype. Metabolic labelling experiments on transduced fibroblasts exhibited, in the medium and in cellular lysates, polypeptide forms of 84 and 80 kDa respectively related to the precursor and mature forms of the enzyme. The enzyme secreted by transduced MPS IIIB fibroblasts was endocytosed in deficient cells by the mannose 6-phosphate system. Thus we show that lentiviral vectors may provide a therapeutic approach for the treatment of MPS IIIB disease.

Original languageEnglish
Pages (from-to)747-753
Number of pages7
JournalBiochemical Journal
Volume364
Issue number3
DOIs
Publication statusPublished - Jun 15 2002

Fingerprint

Mucopolysaccharidosis III
Gene transfer
Fibroblasts
Acetylglucosaminidase
Glycosaminoglycans
Genes
Enzymes
Viruses
Labeling
Virus Integration
Complementary DNA
Experiments
Virus Diseases
Endocytosis
Peptides
Therapeutics
Genome
Phenotype
Polymerase Chain Reaction
Mutation

Keywords

  • α-N-acetylglucosaminidase
  • Lysosomal diseases
  • Sanfilippo B syndrome
  • Third-generation lentiviral vector

ASJC Scopus subject areas

  • Biochemistry

Cite this

Correction of mucopolysaccharidosis type IIIB fibroblasts by lentiviral vector-mediated gene transfer. / Villani, Guglielmo R D; Follenzi, Antonia; Vanacore, Borghina; Di Domenico, Carmela; Naldini, Luigi; Di Natale, Paola.

In: Biochemical Journal, Vol. 364, No. 3, 15.06.2002, p. 747-753.

Research output: Contribution to journalArticle

Villani, GRD, Follenzi, A, Vanacore, B, Di Domenico, C, Naldini, L & Di Natale, P 2002, 'Correction of mucopolysaccharidosis type IIIB fibroblasts by lentiviral vector-mediated gene transfer', Biochemical Journal, vol. 364, no. 3, pp. 747-753. https://doi.org/10.1042/BJ20011872
Villani, Guglielmo R D ; Follenzi, Antonia ; Vanacore, Borghina ; Di Domenico, Carmela ; Naldini, Luigi ; Di Natale, Paola. / Correction of mucopolysaccharidosis type IIIB fibroblasts by lentiviral vector-mediated gene transfer. In: Biochemical Journal. 2002 ; Vol. 364, No. 3. pp. 747-753.
@article{0a42ba86869f492099649bb59f59f354,
title = "Correction of mucopolysaccharidosis type IIIB fibroblasts by lentiviral vector-mediated gene transfer",
abstract = "Mucopolysaccharidosis type IIIB (MPS IIIB; or Sanfilippo syndrome type B) is a lysosomal disease, due to glycosaminoglycan storage caused by mutations on the α-N-acetylglucosaminidase (NAGLU) gene. The disease is characterized by neurological dysfunction but relatively mild somatic manifestations. No effective treatment is available for affected patients. In the present study, we evaluated the role of a lentiviral vector as the transducing agent of NAGLU cDNA in MPS IIIB fibroblasts. The vector expressed high transduction efficiency and high levels of enzymic activity, 20-fold above normal levels, persisting for at least 2 months. PCR experiments confirmed the integration of the viral vector into the target genome. The NAGLU activity restored by virus infection was sufficient to normalize glycosaminoglycan accumulation, which is directly responsible for the disease phenotype. Metabolic labelling experiments on transduced fibroblasts exhibited, in the medium and in cellular lysates, polypeptide forms of 84 and 80 kDa respectively related to the precursor and mature forms of the enzyme. The enzyme secreted by transduced MPS IIIB fibroblasts was endocytosed in deficient cells by the mannose 6-phosphate system. Thus we show that lentiviral vectors may provide a therapeutic approach for the treatment of MPS IIIB disease.",
keywords = "α-N-acetylglucosaminidase, Lysosomal diseases, Sanfilippo B syndrome, Third-generation lentiviral vector",
author = "Villani, {Guglielmo R D} and Antonia Follenzi and Borghina Vanacore and {Di Domenico}, Carmela and Luigi Naldini and {Di Natale}, Paola",
year = "2002",
month = "6",
day = "15",
doi = "10.1042/BJ20011872",
language = "English",
volume = "364",
pages = "747--753",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Correction of mucopolysaccharidosis type IIIB fibroblasts by lentiviral vector-mediated gene transfer

AU - Villani, Guglielmo R D

AU - Follenzi, Antonia

AU - Vanacore, Borghina

AU - Di Domenico, Carmela

AU - Naldini, Luigi

AU - Di Natale, Paola

PY - 2002/6/15

Y1 - 2002/6/15

N2 - Mucopolysaccharidosis type IIIB (MPS IIIB; or Sanfilippo syndrome type B) is a lysosomal disease, due to glycosaminoglycan storage caused by mutations on the α-N-acetylglucosaminidase (NAGLU) gene. The disease is characterized by neurological dysfunction but relatively mild somatic manifestations. No effective treatment is available for affected patients. In the present study, we evaluated the role of a lentiviral vector as the transducing agent of NAGLU cDNA in MPS IIIB fibroblasts. The vector expressed high transduction efficiency and high levels of enzymic activity, 20-fold above normal levels, persisting for at least 2 months. PCR experiments confirmed the integration of the viral vector into the target genome. The NAGLU activity restored by virus infection was sufficient to normalize glycosaminoglycan accumulation, which is directly responsible for the disease phenotype. Metabolic labelling experiments on transduced fibroblasts exhibited, in the medium and in cellular lysates, polypeptide forms of 84 and 80 kDa respectively related to the precursor and mature forms of the enzyme. The enzyme secreted by transduced MPS IIIB fibroblasts was endocytosed in deficient cells by the mannose 6-phosphate system. Thus we show that lentiviral vectors may provide a therapeutic approach for the treatment of MPS IIIB disease.

AB - Mucopolysaccharidosis type IIIB (MPS IIIB; or Sanfilippo syndrome type B) is a lysosomal disease, due to glycosaminoglycan storage caused by mutations on the α-N-acetylglucosaminidase (NAGLU) gene. The disease is characterized by neurological dysfunction but relatively mild somatic manifestations. No effective treatment is available for affected patients. In the present study, we evaluated the role of a lentiviral vector as the transducing agent of NAGLU cDNA in MPS IIIB fibroblasts. The vector expressed high transduction efficiency and high levels of enzymic activity, 20-fold above normal levels, persisting for at least 2 months. PCR experiments confirmed the integration of the viral vector into the target genome. The NAGLU activity restored by virus infection was sufficient to normalize glycosaminoglycan accumulation, which is directly responsible for the disease phenotype. Metabolic labelling experiments on transduced fibroblasts exhibited, in the medium and in cellular lysates, polypeptide forms of 84 and 80 kDa respectively related to the precursor and mature forms of the enzyme. The enzyme secreted by transduced MPS IIIB fibroblasts was endocytosed in deficient cells by the mannose 6-phosphate system. Thus we show that lentiviral vectors may provide a therapeutic approach for the treatment of MPS IIIB disease.

KW - α-N-acetylglucosaminidase

KW - Lysosomal diseases

KW - Sanfilippo B syndrome

KW - Third-generation lentiviral vector

UR - http://www.scopus.com/inward/record.url?scp=0037097043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037097043&partnerID=8YFLogxK

U2 - 10.1042/BJ20011872

DO - 10.1042/BJ20011872

M3 - Article

C2 - 12049639

AN - SCOPUS:0037097043

VL - 364

SP - 747

EP - 753

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -